<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Physicians Review Diagnosis and Management of BPDCN

by Targeted Oncology | July 27, 2023
placeholder

During a Targeted Oncology™ Case-Based Roundtable™ event, Daniel Pollyea, professor of medicine at CU School of Medicine, and participants discussed the diagnosis and treatment of a patient with blastic plasmacytoid dendritic cell neoplasm.

Topics: Press Coverage